Skip to content

CDR

Not Your Mother’s supports breast cancer organization

Not Your Mother’s hair care plans to donate 10% of all of its online sales during October to the Young Survival Coalition (YSC) in recognition of Breast Cancer Awareness Month. The company said that in addition to the donation through business on its nymbrands.

Walgreens, Express Scripts settle contract dispute

Walgreens, Express Scripts settle contract dispute

Walgreen Co. and Express Scripts Inc. have reached a multiyear pharmacy network agreement that includes rates and terms under which the nation’s largest drug chain will participate in the broadest Express Scripts retail pharmacy network available to new and existing clients.

VIVUS gets FDA OK for obesity drug

VIVUS Inc. has been cleared by the Food and Drug Administration to market Qsymia, a weight-loss pill aimed at adults struggling with obesity and related health conditions.

Winn-Dixie rolls out prescription discount program

Winn-Dixie has launched a prescription savings program offering deep discounts on more than 400 generic drugs and various levels of savings on brand-name medications and other generics. The Rx discount program runs through the Winn-Dixie Reward Card.

NACDS, NCPA brief Senate caucus on Rx abuse

The National Association of Chain Drug Stores and the National Community Pharmacists Association provided comment to a Senate caucus on the pharmacy sector’s engagement in the prevention of prescription drug abuse.

Duane Reade promotes electric vehicle use

To help reduce vehicle air pollution, Duane Reade is asking to New Yorkers which of its drug stores should be served solely by electric trucks. The Manhattan-based drug chain, part of Walgreen Co.

Lannett appoints new chairman

Jeffrey Farber, vice chairman at Lannett Co., has been named chairman, succeeding Ronald West. The generic drug maker said Monday that Farber takes over the chairman’s post effective immediately.

RxAlly names general counsel

Tom O’Grady has joined pharmacy alliance RxAlly as general counsel and executive vice president of corporate development. RxAlly said Monday that O’Grady, previously with the law firm McGuireWoods LLP, brings more than 30 years of corporate and transactional law experience to the company.

Par Pharma to be sold to TPG

Par Pharmaceutical Cos. has agreed to be acquired by private equity firm TPG in a deal valued at $1.9 billion. The generic drug and specialty pharmaceutical company said Monday that under the agreement, Par can solicit proposals from other parties until Aug. 24, and its board plans to do so. If